Prognostic factors in metastatic testicular cancer
Open Access
- 1 February 1987
- journal article
- Published by Wiley in International Journal of Andrology
- Vol. 10 (1), 225-237
- https://doi.org/10.1111/j.1365-2605.1987.tb00188.x
Abstract
The prognosis for metastatic testicular cancer has been analysed in seven reports using multivariate analysis. Serum hCG is the most important factor. Volume of metastases, serum LDH and serum AFP are also of prognostic value. Bone, liver, nodal or retroperitoneal metastases are not independent prognostic factors. The prognosis for extragonadal nonseminomas remains in dispute. Future studies should categorize poor prognosis patients using one of the several available prognostic formulas. No consensus yet exists on optimal treatment for such patients.Keywords
This publication has 17 references indexed in Scilit:
- Multivariate analysis of prognostic variables in patients with disseminated non‐seminomatous testicular cancer: results from an EORTC multi‐institutional phase III studyInternational Journal of Andrology, 1987
- Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patientsAmerican Journal Of Medicine, 1986
- High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumorsEuropean Journal of Cancer and Clinical Oncology, 1986
- Prognostic factors for favorable outcome in disseminated germ cell tumors.Journal of Clinical Oncology, 1986
- Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.Journal of Clinical Oncology, 1985
- Prognostic Significance of a Decline in Serum Human Chorionic Gonadotropin Levels After Initial Chemotherapy for Advanced Germ-Cell CarcinomaAnnals of Internal Medicine, 1984
- High-Dose Cisplatin in Hypertonic SalineAnnals of Internal Medicine, 1984
- Tumour-marker levels and prognosis in malignant teratoma of the testisBritish Journal of Cancer, 1980